Navigation Links
Trending HealthEconomics.Com Pharma Pricing, Reimbursement, and Health Policy Stories Show Healthcare Payers Aren’t Taking Drug Prices Laying Down
Date:1/17/2013

Ponte Vedra Beach, Florida (PRWEB) January 17, 2013

The most-read story in HealthEconomics.Com HealthCare Value and Market Access News for the week ending January 12, 2012 examined the annual price tag for Gattex, a treatment for short bowel syndrome, at $295,000 per year. The price was based on Gattex marketer’s analysis of competitors, as well as hospitalization costs avoided. The inpatient cost comparison story will be used with payers, and the company found that patients, physicians, and insurers were willing to pay more than what stock analysts initially predicted. Gattex is an orphan drug, designed to reduce intravenous feedings after resection and partial removal of the small intestine, and is the first drug approved for the treatment of small bowel syndrome since 2004. Recent reports indicate that about 3,000 patients will potentially benefit from such treatment.

Another top story on HealthEconomics.Com explored the record number of 39 drug approvals by the Food & Drug Administration (FDA) in 2012, a level not seen since 1996 when 53 new drugs were approved. FDA has been touting their productivity level for meeting or exceeding nearly all PDUFA goals for application review.    This story is featured on HealthEconomics.Com News on healthcare trends.

Is a buying spree in store for the pharmaceutical industry? Another frequently-read story explored how big pharma is shoring up their bank balances, and their need to fill revenue gaps left by the patent cliff. One solution the industry appears to be pursuing is to buy companies with high-potential drugs in the pipeline, rather than to wait for their own R&D to produce returns. The story is featured on HealthEconomics.Com Pharmaceutical Industry News.

About HealthEconomics.Com: A pioneer in the field, HealthEconomics.Com is the global authority in healthcare value and pharma market access. Each day, HealthEconomics.Com compiles the latest news, policy updates, resources, conferences, and jobs for BioPharma’s professionals involved in health economics, outcomes research, market access, and pricing. A trusted resource, HealthEconomics.Com’s comprehensive content is carefully selected by a discerning health economist editor, making it the most visited website for healthcare value and market access in the industry, with visitors encompassing all corners of the globe.

News Media interested in receiving the most current information on healthcare value and market access may obtain a free subscription to HealthEconomics.Com Pharmaceutical News by visiting the site or by subscribing to the HealthEconomics.Com Newsletter.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10330071.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Trending HealthEconomics.Com Pharma Pricing, Reimbursement, and Health Policy Stories Feature Rising Trend in Pharma Price Cuts to Secure Reimbursement
2. HealthEconomics.Com Appoints New Director of Information Technology and Operations
3. PharmAthene To Present At The Noble Financial 9th Annual Equity Conference On Tuesday, January 22, 2013
4. Eckert & Ziegler Vitalea Science and Korea-based BioCore Bring Human Microdosing to Korea to Address the Needs of the Emergent Pharmaceutical Industry
5. Genedata Screener Adopted for all Plate-based Screening by Major Pharmas
6. UPM Pharmaceuticals Enhances its Pre-Formulation Capabilities
7. BulletinHealthcare a TOP 10 “Most Innovative Company” of 2012 According to Pharma Marketing Publication PM360
8. Biosim Pharmaceuticals, Manufacturers of Generic ACTHAR, to Participate at Biotech Showcase 2013
9. Asia-Pacific Active Pharmaceutical Ingredients (APIs) Market Analysis & Forecasts to 2017 in New Research Report @ RnRMarketResearch.com
10. Rafarma Pharmaceuticals, Inc. Achieves Full Certification
11. K-V Pharmaceutical Secures Commitment for $85 Million Loan, Reaches Agreement with Senior Noteholders on Principal Terms of Plan of Reorganization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... At its national board ... Suneel I. Sheikh, the co-founder, CEO and chief research scientist of Minnesota-based Advanced ... for membership in ARCS Alumni Hall of Fame . ASTER Labs is ...
(Date:10/11/2017)... Alto, CA, USA (PRWEB) , ... October 11, 2017 , ... ... set to take place on 7th and 8th June 2018 in San Francisco, CA. ... policy influencers as well as several distinguished CEOs, board directors and government officials from ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
Breaking Biology Technology:
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
(Date:3/24/2017)... 2017 Research and Markets has announced the ... & Trends - Industry Forecast to 2025" report to their ... The Global ... CAGR of around 15.1% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
Breaking Biology News(10 mins):